Mechanism of Action and Impact of the New Coronavirus Vaccine
DOI:
https://doi.org/10.54097/hset.v54i.9719Keywords:
Covid vaccinations, mRNA, Advantages, Disadvantages.Abstract
A massive global health disaster caused by the novel coronavirus (COVID-19) pandemic has harmed millions of people and resulted in severe suffering and mortality. Since the COVID-19 epidemic, research into mRNA vaccines and therapies has expanded. To achieve disease preventive and treatment goals, mRNA vaccines entail injecting a synthetic mRNA sequence encoding protein antigen into the human body, instructing the body to express the right protein, and prompting the body to evoke a specific immune response. As a result, efforts have been launched around the world to develop a vaccine that can protect against the virus and halt its spread. The mode of action and effects of the novel coronavirus will be examined in this essay. The background, literature review, and research progress, motivation and research framework, case study, and influence on the human body will all be covered in the article. All of these are predicated on the mRNA relationship. Finally, the article will include a conclusion that summarizes the findings of the study as well as its limitations and future prospects.
Downloads
References
The safety of Covid-19 mRNA vaccines: a review Pratibha Anand and Vincent P. Stahel Patient Safety in Surgery volume 15, Article number: 20 (2021).
Jung Woo Park, Philip N.P. Lagniton, Yu Liu, and Ren-He Xu. National Library of Medicine mRNA vaccine for covid-19: what, why and how Int J Biol Sci. 2021; 17 (6): 1446 – 1460. Published online 2021 Apr 10.
Enyue Fang, Xiaohui Liu, Miao Li, Zelun Zhang, Lifang Song, Baiyu Zhu, Xiaohong Wu, Jingjing Liu, Danhua Zhao & Yuhua Li. Advances in COVID-19 mRNA vaccine development Signal Transduction and Targeted Therapy volume 7, Article number: 94 (2022).
Qingrui Huang, Jiawei Zeng, Jinghua Yan. COVID-19 mRNA vaccines ScienceDirect Journal of Genetics and Genomics Received 5 January 2021, Revised 31 January 2021, Accepted 1 February 2021, Available online 15 March 2021, Version of Record 26 June 2021.
Ned Lewis, MPH Kristin Goddard, MPH et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination JAMA 21; 326 (14): 1390 - 1399.
Shyh Poh Teo, MBChB, FRACP Review of CVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273 SAGE journals Volume 35, Issue 6 April 12, 2021.
Ai-ris Y. Collier, MD; Katherine McMahan, MS, Jingyou Yu, PhD et al Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women JAMA JAMA. 2021; 325 (23): 2370 - 2380.
Na-Na Zhang6, Xiao-Feng Li 1, Yong-Qiang Deng et al.
A Thermostable mRNA Vaccine against COVID-19 ScienceDirect. Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China3 Pages 1271 - 1283.e16 2020.
Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt, Heleen Dewitte. The dawn of mRNA vaccines: The COVID - 19 case ScienceDirect 10, May 2021, pages 511 - 520.
Balraj Singh, Parminder Kaur, Leon Cedeno, Taulant Brahimi, Prem Patel, Hartaj Virk, Fayez Shamoon, and Manesh Bikkina. COVID-19 mRNA Vaccine and Myocarditis National Library of medicine 2021.
Noa Dagan, Noam Barda, Tal Biron-Shental, Maya Makov-Assif, Calanit Key, Isaac S. Kohane, Miguel A. Hernán, Marc Lipsitch, Sonia Hernandez-Diaz, Ben Y. Reis & Ran D. Balicer. Effectiveness of the BNT162b2 mRNA COVID - 19 vaccine in pregnancy 2021.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







